ICON PLC (ICLR)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $14.58B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICON PLC (ICLR) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, ICON reported EPS of $2.46, above the $2.40 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
Analysts' consensus for the quarter ending Dec 31, 2026 is 14.3% above the $2.52 reported for the quarter ended Dec 31, 2025.
ICLR's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
ICLR Earnings Call
The latest ICLR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, ICLR beat 32, missed 2 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $2.02B, down 1.0% from $2.04B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.46 | $2.40 | N/A | +2.50% | Beat | -25.7% | 13 | 1 up, 5 down | Oct 27, 2026 | $2.02B |
| Jun 30, 2026 | $2.35 | $2.26 | $2.13 - $2.62 | +3.98% | Beat | -27.9% | 15 | 5 up, 6 down | Jul 29, 2026 | $2.06B |
| Mar 31, 2026 | $2.22 | $2.16 | N/A | +2.78% | Beat | -30.4% | 13 | N/A | May 27, 2026 | $2.03B |
| Dec 31, 2025 | $2.52 | $3.31 | $2.77 - $3.34 | -23.87% | Miss | -26.5% | 14 | 0 up, 6 down | Feb 25, 2026 | $2.19B |
| Sep 30, 2025 | $3.31 | $3.28 | $3.03 - $3.42 | +0.91% | Beat | -1.2% | 15 | 1 up, 4 down | Oct 22, 2025 | $2.04B |
| Jun 30, 2025 | $3.26 | $3.18 | $3.02 - $3.29 | +2.52% | Beat | -13.1% | 15 | 2 up, 5 down | Jul 23, 2025 | $2.02B |
| Mar 31, 2025 | $3.19 | $3.09 | $2.80 - $3.30 | +3.24% | Beat | -8.1% | 16 | 1 up, 9 down | Apr 30, 2025 | $2.00B |
| Dec 31, 2024 | $3.43 | $3.43 | $3.38 - $3.49 | +0.14% | Beat | -0.9% | 16 | 3 up, 2 down | Feb 19, 2025 | $2.04B |
| Sep 30, 2024 | $3.35 | $3.84 | $3.61 - $3.93 | -12.76% | Miss | +1.5% | 16 | 1 up, 1 down | Oct 23, 2024 | $2.03B |
| Jun 30, 2024 | $3.75 | $3.67 | $3.58 - $3.75 | +2.18% | Beat | +20.6% | 15 | 4 up, 0 down | Jul 24, 2024 | $2.12B |
| Mar 31, 2024 | $3.47 | $3.41 | $3.12 - $3.52 | +1.76% | Beat | +19.7% | 15 | 0 up, 1 down | Apr 24, 2024 | $2.09B |
| Dec 31, 2023 | $3.46 | $3.44 | $3.16 - $3.55 | +0.58% | Beat | +10.5% | 15 | 1 up, 0 down | Feb 21, 2024 | $2.07B |
| Sep 30, 2023 | $3.30 | $3.28 | $3.21 - $3.36 | +0.61% | Beat | +10.0% | 15 | 2 up, 1 down | Oct 25, 2023 | $2.06B |
| Jun 30, 2023 | $3.11 | $3.08 | $2.95 - $3.13 | +0.97% | Beat | +8.7% | 15 | 1 up, 1 down | Jul 26, 2023 | $2.02B |
| Mar 31, 2023 | $2.90 | $2.87 | $2.52 - $3.09 | +1.05% | Beat | +5.1% | 15 | 0 up, 1 down | Apr 26, 2023 | $1.98B |
| Dec 31, 2022 | $3.13 | $3.05 | $2.93 - $3.13 | +2.62% | Beat | +19.0% | 14 | 0 up, 0 down | Feb 22, 2023 | $1.96B |
| Sep 30, 2022 | $3.00 | $2.94 | $2.76 - $3.02 | +2.04% | Beat | +17.6% | 14 | 3 up, 1 down | Nov 2, 2022 | $1.94B |
| Jun 30, 2022 | $2.86 | $2.79 | $2.63 - $2.87 | +2.51% | Beat | +34.9% | 13 | 0 up, 0 down | Jul 27, 2022 | $1.94B |
| Mar 31, 2022 | $2.76 | $2.69 | $2.63 - $2.79 | +2.60% | Beat | +34.0% | 11 | 2 up, 0 down | Apr 27, 2022 | $1.90B |
| Dec 31, 2021 | $2.63 | $2.62 | $2.40 - $2.71 | +0.38% | Beat | +38.4% | 12 | 1 up, 0 down | Feb 22, 2022 | $1.89B |
| Sep 30, 2021 | $2.55 | $2.46 | $1.78 - $2.70 | +3.66% | Beat | +48.3% | 12 | 0 up, 0 down | Nov 3, 2021 | $1.87B |
| Jun 30, 2021 | $2.12 | $2.11 | $1.93 - $2.14 | +0.47% | Beat | +76.7% | 14 | N/A | Jul 21, 2021 | $871.15M |
| Mar 31, 2021 | $2.06 | $1.97 | $1.88 - $2.12 | +4.57% | Beat | +21.2% | 15 | N/A | Apr 28, 2021 | $858.20M |
| Dec 31, 2020 | $1.90 | $1.83 | $1.78 - $1.88 | +3.83% | Beat | +3.8% | 16 | N/A | Feb 24, 2021 | $760.23M |
| Sep 30, 2020 | $1.72 | $1.54 | $1.44 - $1.63 | +11.69% | Beat | -1.1% | 16 | N/A | Oct 21, 2020 | $701.73M |
| Jun 30, 2020 | $1.20 | $1.10 | $1.01 - $1.18 | +9.09% | Beat | -29.0% | 17 | N/A | Jul 22, 2020 | $620.23M |
| Mar 31, 2020 | $1.70 | $1.70 | $1.51 - $1.84 | 0.00% | In line | +4.3% | 16 | N/A | Apr 22, 2020 | $715.10M |
| Dec 31, 2019 | $1.83 | $1.83 | $1.80 - $1.85 | 0.00% | In line | +13.0% | 15 | N/A | Feb 19, 2020 | $725.41M |
| Sep 30, 2019 | $1.74 | $1.74 | $1.71 - $1.79 | 0.00% | In line | +13.0% | 13 | N/A | Oct 23, 2019 | $710.44M |
| Jun 30, 2019 | $1.69 | $1.68 | $1.64 - $1.70 | +0.60% | Beat | +11.9% | 15 | N/A | Jul 24, 2019 | $695.14M |
| Mar 31, 2019 | $1.63 | $1.60 | $1.54 - $1.65 | +1.88% | Beat | +14.8% | 14 | N/A | May 1, 2019 | $674.85M |
| Dec 31, 2018 | $1.62 | $1.60 | $1.57 - $1.64 | +1.25% | Beat | +13.3% | 14 | N/A | Feb 20, 2019 | $679.02M |
| Sep 30, 2018 | $1.54 | $1.54 | $1.51 - $1.56 | 0.00% | In line | +14.1% | 15 | N/A | Oct 24, 2018 | $655.02M |
| Jun 30, 2018 | $1.51 | $1.48 | $1.46 - $1.50 | +2.03% | Beat | +15.3% | 13 | N/A | Jul 25, 2018 | $641.61M |
| Mar 31, 2018 | $1.42 | $1.42 | $1.39 - $1.46 | 0.00% | In line | +10.1% | 12 | N/A | May 2, 2018 | $620.13M |
| Dec 31, 2017 | $1.43 | $1.42 | $1.39 - $1.44 | +0.70% | Beat | +13.5% | 14 | N/A | Feb 15, 2018 | $455.14M |
| Sep 30, 2017 | $1.35 | $1.32 | $1.27 - $1.37 | +2.27% | Beat | +13.4% | 14 | N/A | Oct 26, 2017 | $440.32M |
| Jun 30, 2017 | $1.31 | $1.30 | $1.26 - $1.36 | +0.77% | Beat | +14.9% | 14 | N/A | Jul 27, 2017 | $431.02M |
| Mar 31, 2017 | $1.29 | $1.28 | N/A | +0.78% | Beat | +15.2% | N/A | N/A | Apr 27, 2017 | $431.95M |
| Dec 31, 2016 | $1.26 | $1.26 | N/A | 0.00% | In line | +13.5% | N/A | N/A | Feb 16, 2017 | $435.13M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $12.28, down 12.3% from the year before. It was $4.71 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $12.28 | -12.3% |
| Dec 31, 2024 | $14.00 | +9.6% |
| Dec 31, 2023 | $12.77 | +8.7% |
| Dec 31, 2022 | $11.75 | +25.5% |
| Dec 31, 2021 | $9.36 | +43.6% |
| Dec 31, 2020 | $6.52 | -5.4% |
| Dec 31, 2019 | $6.89 | +13.1% |
| Dec 31, 2018 | $6.09 | +13.2% |
| Dec 31, 2017 | $5.38 | +14.2% |
| Dec 31, 2016 | $4.71 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 18 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 10,220 | 18 | |
| 2026Q2 | Jun 30, 2026 | 8,943 | 18 | |
| 2026Q1 | Mar 31, 2026 | 6,896 | 18 | |
| 2025Q3 | Sep 30, 2025 | 8,178 | 20 | |
| 2025Q2 | Jun 30, 2025 | 7,507 | 19 | |
| 2025Q1 | Mar 31, 2025 | 7,908 | 20 | |
| 2024Q4 | Dec 31, 2024 | 8,989 | 20 | |
| 2024Q3 | Sep 30, 2024 | 9,689 | 20 |
2026Q3 Earnings Call
Opening remarks
Kate Haven Vice President of Investor Relations Hello, and thank you for joining us today. I am joined on the call by our CEO, Barry Balfe, and our CFO, Nigel Clerkin. I would like to note that this call is webcast and that there are slides available to download on our website to accompany today's call. Certain statements in today's call will be forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, and listeners are cautioned that forward-looking statements are not guarantees of future performance. Forward-looking statements are only as of the date they are made, and we do not undertake any obligation to update publicly any forward-looking statements, either as a result of new information, future events, or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in the most recently filed Annual Report on Form 20-F. This presentation includes selected non-GAAP financial measures, which Barry and Nigel will be referencing in their prepared remarks. For a presentation of the most directly comparable GAAP financial measures, please refer to the section of the press release dated October 27, 2026, titled Consolidated Statements of Operations. While non-GAAP financial measures are not superior to or a substitute for comparable GAAP measures, we believe certain non-GAAP information is more useful to investors for historical comparison purposes. Included in the press release and the earnings slides, you will note a reconciliation of non-GAAP measures. Adjusted EBITDA, adjusted net income, and adjusted diluted earnings per share exclude amortization, stock-based compensation, foreign currency gains and losses, restructuring, transaction, integration-related and other adjustments, transaction-related financing costs, fair value movement on investments in equity, goodwill impairment, loss on disposal of subsidiary undertakings, impairment of nonfinancial assets, and their related taxation effect. We will be limiting the call today to one hour. In the interest of time, we ask participants to keep their questions to one each. I would now like to hand the call over to our CEO, Barry Balfe.
Barry Balfe CEO Thank you, Kate. Our third-quarter results mark another clear step forward, in line with the plan that we set out to deliver earlier this year. Strong commercial momentum, continued earnings growth, and disciplined execution continue to reinforce our confidence in the outlook for the business and the opportunities ahead as we move into 2027. Q3 results were very much in line with our expectations, and I was particularly pleased that we saw progress in the areas that we had previously indicated.
Frequently Asked Questions About ICLR
Did ICLR beat earnings estimates last quarter?
Yes. ICON reported EPS of $2.46 for the quarter ended Sep 30, 2026, above the $2.40 estimate, a 2.50% surprise.
What EPS do analysts expect from ICLR next quarter?
The consensus EPS estimate for ICON for the quarter ending Dec 31, 2026 is $2.88 from 19 analysts, with estimates from $2.70 to $3.08.
How often does ICLR beat earnings estimates?
ICON beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of -0.97%.
ICLR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors